0001802369-23-000002.txt : 20230810 0001802369-23-000002.hdr.sgml : 20230810 20230810141317 ACCESSION NUMBER: 0001802369-23-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230810 DATE AS OF CHANGE: 20230810 EFFECTIVENESS DATE: 20230810 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ADARx Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001802369 IRS NUMBER: 844145188 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-489353 FILM NUMBER: 231158541 BUSINESS ADDRESS: STREET 1: 5871 OBERLIN DRIVE, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-283-9472 MAIL ADDRESS: STREET 1: 5871 OBERLIN DRIVE, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 D 1 primary_doc.xml X0708 D LIVE 0001802369 ADARx Pharmaceuticals, Inc. 5871 Oberlin Drive, Suite 200 San Diego CA CALIFORNIA 92121 858-283-9472 DELAWARE None None Corporation true 2019 Zhen Li 5871 Oberlin Drive, Suite 200 San Diego CA CALIFORNIA 92121 Executive Officer Director Promoter Rui Zhu 5871 Oberlin Drive, Suite 200 San Diego CA CALIFORNIA 92121 Executive Officer Lorence Kim 5871 Oberlin Drive, Suite 200 San Diego CA CALIFORNIA 92121 Director Simeon George 5871 Oberlin Drive, Suite 200 San Diego CA CALIFORNIA 92121 Director Yuan (Eliza) Sun 5871 Oberlin Drive, Suite 200 San Diego CA CALIFORNIA 92121 Director Erez Chimovits 5871 Oberlin Drive, Suite 200 San Diego CA CALIFORNIA 92121 Director Carl Gordon 5871 Oberlin Drive, Suite 200 San Diego CA CALIFORNIA 92121 Director Judith Li 5871 Oberlin Drive, Suite 200 San Diego CA CALIFORNIA 92121 Director Sheila Gujrathi 5871 Oberlin Drive, Suite 200 San Diego CA CALIFORNIA 92121 Director Ricky Sun 5871 Oberlin Drive, Suite 200 San Diego CA CALIFORNIA 92121 Director Chen Yu 5871 Oberlin Drive, Suite 200 San Diego CA CALIFORNIA 92121 Director Biotechnology Decline to Disclose 06b false 2023-08-02 false true false 0 200000012 200000012 0 false 28 0 0 0 false ADARx Pharmaceuticals, Inc. Zhen Li Zhen Li President and Chief Executive Officer 2023-08-10